Biopharmaceutical News and Research

RSS
Almirall's Ebglyss recommended by NICE for NHS atopic dermatitis patients

Almirall's Ebglyss recommended by NICE for NHS atopic dermatitis patients

Click-like chemistry enables rapid development of LNPs for enhanced mRNA delivery

Click-like chemistry enables rapid development of LNPs for enhanced mRNA delivery

Agreement to explore Optimer vehicles for targeted delivery of siRNA

Agreement to explore Optimer vehicles for targeted delivery of siRNA

ELRIG UK and The Protein Society Partner to advance protein sciences in drug discovery

ELRIG UK and The Protein Society Partner to advance protein sciences in drug discovery

UT Health Science Center awarded $1.58M grant to study cancer disparities among Black women

UT Health Science Center awarded $1.58M grant to study cancer disparities among Black women

WEHI spinout aims to revolutionize the development of cancer drugs

WEHI spinout aims to revolutionize the development of cancer drugs

Gyros Protein Technologies introduces Gyrolab Generic Anti-AAV Kit to support gene therapy development

Gyros Protein Technologies introduces Gyrolab Generic Anti-AAV Kit to support gene therapy development

Enterprise Therapeutics appoints Dr Renu Gupta as Chief Medical Officer and Dr Janet Hammond as Non-Executive Director

Enterprise Therapeutics appoints Dr Renu Gupta as Chief Medical Officer and Dr Janet Hammond as Non-Executive Director

Enterprise Therapeutics publishes preclinical profile of ETD001, a novel inhaled ENaC blocker

Enterprise Therapeutics publishes preclinical profile of ETD001, a novel inhaled ENaC blocker

InDevR and Sino Biological team up to deliver multiplexed analytical solutions for mRNA vaccine and cell & gene therapy

InDevR and Sino Biological team up to deliver multiplexed analytical solutions for mRNA vaccine and cell & gene therapy

Novel small molecule oral antiviral could be a game-changer in the fight against future pandemics

Novel small molecule oral antiviral could be a game-changer in the fight against future pandemics

DefiniGEN and Atelerix collaborate to ship in vitro cell models internationally without the need for freezing or cryopreservation

DefiniGEN and Atelerix collaborate to ship in vitro cell models internationally without the need for freezing or cryopreservation

UMSOM receives $3.96 million grant for maternal vaccine against neonatal sepsis

UMSOM receives $3.96 million grant for maternal vaccine against neonatal sepsis

Refeyn strengthens capability with new US Headquarters in Boston area

Refeyn strengthens capability with new US Headquarters in Boston area

CYTENA unveils revolutionary C.WASH PLUS: The future of microplate washing and dispensing

CYTENA unveils revolutionary C.WASH PLUS: The future of microplate washing and dispensing

PhoreMost introduces GlueSEEKER platform for discovery of molecular glue degraders

PhoreMost introduces GlueSEEKER platform for discovery of molecular glue degraders

RedShiftBio launches Aurora TX: Revolutionizing RNA and protein analysis with ultra-sensitive microfluidic modulation spectroscopy and thermal ramping capability

RedShiftBio launches Aurora TX: Revolutionizing RNA and protein analysis with ultra-sensitive microfluidic modulation spectroscopy and thermal ramping capability

ArgusEye closes €2.8 million funding to accelerate bioprocessing

ArgusEye closes €2.8 million funding to accelerate bioprocessing

UT Health San Antonio leads effort for developing oral vaccine against chlamydia

UT Health San Antonio leads effort for developing oral vaccine against chlamydia

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.